Nasdaq: XLRN

Acceleron Pharma Inc.

Acceleron Pharma is a clinical biotechnology company focused on the discovery, development, and commercialization of protein therapeutics for beta thalesemia and muscle loss. The company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-β) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body which represent a diverse and under-explored set of drug targets. The company is completing its phase III registration trial for a best in class beta thelessemia product with Cellgene.